Delivery Order SPE2DB20D9214-SPE2DB24FD4RR
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Mirena 52 mg systems. The order has a potential value of $71,040 and a completion date of February 14, 2024. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to provide a variety of pharmaceutical and medical supplies to support military treatment facilities worldwide. The...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the MIRENA 52 MG SYSTEMS pharmaceutical product. The contract has a completion date of February 13, 2024 and a potential value of $2,960.00. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to provide a variety of medical supplies and pharmaceuticals to support military...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a delivery order under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 27, 2025, with an ultimate completion date of September 18, 2025, represents a direct purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA. This delivery order carries no set-aside designation, allowing the woman-owned small business to compete on a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,415.40 to DMS Pharmaceutical Group Inc. on July 28, 2025, for the supply of Mirena 52 mg systems. The award, which carries an ultimate completion date of August 18, 2025, utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Illinois facility. The...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, with an ultimate completion date of October 7, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order represents a single transaction under the company's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,249.24 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems on September 23, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 15, 2025, represents a single delivery against DMS Pharmaceutical Group's larger indefinite delivery contract with the DLA. The award carries no set-aside designation, allowing the woman-owned small business based in Park Ridge, Illinois to compete directly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its Park Ridge...
- The Defense Logistics Agency (DLA) awarded a $59,200.00 firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Mirena 52 mg systems. The contract, which has a completion date of January 31, 2024, is not associated with a larger contract vehicle. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand name and generic prescription and over-the-counter drug supplies to the federal government,...
- The Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Mirena 52 mg systems. The contract, valued at $11,840.00, has an ultimate completion date of September 24, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the SPE2DB program, valued at up to $499,999,999, which runs through...
- SPE2DB20D9214Indefinite Delivery Contract
- SPE2DB20D9214-SPE2DB24FD4RRDelivery Order
The Defense Logistics Agency (DLA) awarded a $21,312.00 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of the pharmaceutical product Mirena 52 mg systems. The delivery order was not set aside for any specific business type. DMS Pharmaceutical Group holds an indefinite delivery contract with DLA to provide various pharmaceutical and medical supplies, including items like atropine, Narcan nasal spray, and intravenous saline, with a potential value up to $5 million through December 2025. The delivery order awarded on January 4, 2024 is for the provision of the Mirena 52 mg systems, with a completion date of January 26, 2024, to support the operations of military treatment facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.3k | 1/4/24 |